Trastuzumab Duocarmazine Tried in HER2+ Breast Cancer ...Middle East

Medscape - News
Patients with unresectable locally advanced or metastatic HER2+ breast cancer were randomly assigned to receive trastuzumab duocarmazine or a physician’s choice. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Trastuzumab Duocarmazine Tried in HER2+ Breast Cancer )

Also on site :